Breaking News Instant updates and real-time market news.

AGN

Allergan

$211.61

6.96 (3.40%)

07:05
09/26/17
09/26
07:05
09/26/17
07:05

Allergan weakness a buying opportunity, says UBS

UBS analyst Marc Goodman said the recent weakness in Allergan is a buying opportunity. He believes he may have been too aggressive with his model, but even with his revised forecast, he said the story and valuation does not change that much and the stock remains very attractive. Goodman said the risk/reward for the Restasis patent case is not good, but he believes the shares have already priced in the risk. Goodman reiterated his Buy rating and $275 price target on Allergan shares.

AGN Allergan
$211.61

6.96 (3.40%)

09/20/17
09/20/17
DOWNGRADE
Target $228

Equal Weight
Allergan cut to Equal Weight on lower margin assumptions at Morgan Stanley
As previously reported, Morgan Stanley analyst David Risinger downgraded Allergan to Equal Weight from Overweight, explaining that he previously projected growth above the average of its Major Pharma peers, but he now has less conviction in its pipeline catalysts, sees more Restasis patent risk and he no longer expects margin expansion because high gross margin products face generic pressures. The analyst lowered his longer-term margin assumptions for Allergan and cut his price target on the stock to $228 from $284.
09/22/17
WELS
09/22/17
NO CHANGE
Target $276
WELS
Outperform
Allergan trial not successful, but overhang removed, says Wells Fargo
Wells Fargo analyst David Maris says the best he can say about Allergan's data today for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis is that Cenicriviroc "seems safe and it may have a benefit in some patients." Overall, the study was not a success, but the good safety and other data support further study, Maris tells investors in a research note titled "Data Mixed, One Overhang Gone." The analyst keeps an Outperform rating on Allergan shares with a $276 price target.
09/25/17
WELS
09/25/17
NO CHANGE
WELS
Outperform
Allergan Refusal to File for Vraylar 'surprising,' says Wells Fargo
Wells Fargo analyst David Maris notes that Allergan received a Refusal to File letter from the FDA regarding its Supplemental New Drug Application, or sNDA, seeking approval for Vraylar, or cariprazine, for the treatment of negative symptoms associated with schizophrenia in adult patients. The analyst believes the news is the latest in a string of setbacks for the company, and says it is" surprising" given management highlighted this indication as a potential growth driver a few weeks ago and did not mention any potential issues with the filing timing. Maris reiterates an Outperform rating on the shares.
09/25/17
WELS
09/25/17
NO CHANGE
WELS
Outperform
Allergan buyback should be seen as good news, says Wells Fargo
Wells Fargo analyst David Maris believes the buyback announcement this morning from Allergan should be taken as good news. The departure of CFO Tess Hilado may create greater uncertainty, but company's reaffirmation of 2017 guidance and Q3 revenue projections are offsetting positives, Maris tells investors in a research note. He keeps an Outperform rating on Allergan.

TODAY'S FREE FLY STORIES

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Ecolab reports Q4 adjusted EPS $1.39, consensus $1.39 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

SMP

Standard Motor

$48.20

0.3 (0.63%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Standard Motor reports Q4 cont ops EPS 54c, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$172.43

-0.56 (-0.32%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Technical Analysis
Technical Take: Apple slips in early trading »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Earnings
Genuine Parts reports Q4 adjusted EPS $1.19, consensus $1.05 »

Reports Q4 revenue $4.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

GPS

Gap

$33.27

-0.06 (-0.18%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Hot Stocks
Gap announces departure of Gap brand President and CEO Jeff Kirwan »

Gap Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

, FALC

FalconStor

$0.19

0.003 (1.65%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Options
Two option delistings on February 20th »

Option delistings…

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

FALC

FalconStor

$0.19

0.003 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUSHA

Rush Enterprises

$42.77

-0.325 (-0.75%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Recommendations
Rush Enterprises analyst commentary  »

Rush Enterprises price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:29
02/20/18
02/20
08:29
02/20/18
08:29
General news
Stocks point to lower start to week as Walmart weighs on Dow »

Stock futures are…

GOOD

Gladstone

$17.65

0.24 (1.38%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Hot Stocks
Gladstone announces sale of Arlington, TX $5.6M »

Gladstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAN

Aaron's

$43.40

-0.39 (-0.89%)

, LOW

Lowe's

$96.31

-0.2 (-0.21%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Recommendations
Aaron's, Lowe's analyst commentary  »

Aaron's Progressive…

AAN

Aaron's

$43.40

-0.39 (-0.89%)

LOW

Lowe's

$96.31

-0.2 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

LVMUY

LVMH

$61.94

0.68 (1.11%)

08:27
02/20/18
02/20
08:27
02/20/18
08:27
Hot Stocks
LVMH names Serge Brunschwig as Chairman and CEO of Fendi »

The LVMH Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$77.27

2.66 (3.57%)

08:26
02/20/18
02/20
08:26
02/20/18
08:26
Earnings
Wabtec reports Q4 adj. EPS 90c, consensus 92c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Mar

ATNX

Athenex

$16.66

-0.11 (-0.66%)

08:25
02/20/18
02/20
08:25
02/20/18
08:25
Hot Stocks
Athenex announces Phase II clinical study results for KX2-391 ointment »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

08:25
02/20/18
02/20
08:25
02/20/18
08:25
General news
Fedspeak is backloaded during the week: »

Fedspeak is backloaded…

IPGP

IPG Photonics

$239.36

-19.71 (-7.61%)

08:23
02/20/18
02/20
08:23
02/20/18
08:23
Recommendations
IPG Photonics analyst commentary  »

IPG Photonics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 30

    May

FELE

Franklin Electric

$44.45

0.35 (0.79%)

08:22
02/20/18
02/20
08:22
02/20/18
08:22
Earnings
Franklin Electric reports Q4 EPS ex-items 42c, consensus 44c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

SNE

Sony

$49.55

0.74 (1.52%)

08:21
02/20/18
02/20
08:21
02/20/18
08:21
Periodicals
Sony to start ride-hailing service in Japan as Uber eyes expansion, CNBC says »

Sony has partnered with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PATK

Patrick Industries

$66.05

-2 (-2.94%)

08:21
02/20/18
02/20
08:21
02/20/18
08:21
Hot Stocks
Patrick Industries sees Metal Moulding acquisition 'immediately accretive' »

Patrick Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKL

Delek Logistics

$31.15

-0.35 (-1.11%)

, GPP

Green Plains Partners

$18.00

0.2 (1.12%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Hot Stocks
Delek Logistics, Green Plains Partners announce formation of logistics JV »

Delek Logistics Partners…

DKL

Delek Logistics

$31.15

-0.35 (-1.11%)

GPP

Green Plains Partners

$18.00

0.2 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

YUM

Yum! Brands

$78.25

-0.72 (-0.91%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Periodicals
Yum's KFC U.K. restaurants facing chicken shortage, shutting branches, FT says »

Yum's KFC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$189.34

-0.7 (-0.37%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Hot Stocks
Perrigo confirms patent challenge with FDA for generic version of Finacea Foam »

Perrigo Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

XLK

Technology Select Sector SPDR

$67.18

-0.1 (-0.15%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$224.19

-1.21 (-0.54%)

, CSRA

CSRA

$40.56

0.04 (0.10%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Recommendations
General Dynamics, CSRA analyst commentary  »

General Dynamics price…

GD

General Dynamics

$224.19

-1.21 (-0.54%)

CSRA

CSRA

$40.56

0.04 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EEM

MSCI Emerging Markets Index

$49.54

-0.16 (-0.32%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Technical Take: MSCI Emerging Markets ETF falls in early trading »

The MSCI Emerging Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.